HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lombardi, P. Articles by Havekes, L. M. Search for Related Content PubMed PubMed Citation Articles by Lombardi, P. Articles by Havekes, L. M. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol 36, 860-867, Copyright © 1995 by Lipid Research, Inc.

ARTICLES

Mutations in the low density lipoprotein receptor gene of familial hypercholesterolemic patients detected by denaturing gradient gel electrophoresis and direct sequencing

P Lombardi, EJ Sijbrands, K van de Giessen, AH Smelt, JJ Kastelein, RR Frants and LM Havekes
TNO-PG, Gaubius Laboratory, Leiden, The Netherlands.

Familial hypercholesterolemia (FH) results from mutations in the low density lipoprotein receptor (LDLR) gene. We applied denaturing gradient gel electrophoresis (DGGE) to screen for sequence variations in the coding and splice site consensus sequences of the LDLR gene. For amplification of each exon by the polymerase chain reaction (PCR), optimal pairs of primers were designed by the MELT 87 computer algorithm. To increase the sensitivity, an artificial GC-clamp was included in either the 5'- or the 3'-end of each fragment. DGGE screening of 32 apparently unrelated heterozygous FH patients revealed 16 unique different aberrant DGGE patterns in 27 patients, while in a group of 32 normal subjects none of these DGGE patterns could be observed, suggesting that the aberrant patterns represent disease- causing mutations. Interestingly, 16 out of 27 patients showed an aberrant DGGE pattern in the part of the gene encoding the ligand binding domain (exons 2-6). Direct solid-phase sequencing of the corresponding exon-specific PCR products revealed the nature of the mutations: three nonsense, four splicing, two frameshift, one silent, and six missense mutations. Six of the mutations have been previously reported, while ten are novel mutations. These results indicate that DGGE provides a reliable method for the detection of the presence of point mutations in the LDLR gene of FH patients, thereby facilitating the introduction of rapid DNA diagnosis for this common and genetically heterogeneous disorder.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				O. W. Souverein, J. C. Defesche, A. H. Zwinderman, J. J.P. Kastelein, and M. W.T. Tanck Influence of LDL-receptor mutation type on age at first cardiovascular event in patients with familial hypercholesterolaemia Eur. Heart J., February 1, 2007; 28(3): 299 - 304. [Abstract] [Full Text] [PDF]

				D. Tejedor, S. Castillo, P. Mozas, E. Jimenez, M. Lopez, M. T. Tejedor, M. Artieda, R. Alonso, P. Mata, L. Simon, et al. Reliable Low-Density DNA Array Based on Allele-Specific Probes for Detection of 118 Mutations Causing Familial Hypercholesterolemia Clin. Chem., July 1, 2005; 51(7): 1137 - 1144. [Abstract] [Full Text] [PDF]

				J. S. Millar, C. Maugeais, K. Ikewaki, D. M. Kolansky, P.H. R. Barrett, E. C. Budreck, R. C. Boston, N. Tada, S. Mochizuki, J. C. Defesche, et al. Complete Deficiency of the Low-Density Lipoprotein Receptor Is Associated With Increased Apolipoprotein B-100 Production Arterioscler Thromb Vasc Biol, March 1, 2005; 25(3): 560 - 565. [Abstract] [Full Text] [PDF]

				O. A. Bodamer, D. Bercovich, M. Schlabach, C. Ballantyne, D. Zoch, and A. L. Beaudet Use of Denaturing HPLC to Provide Efficient Detection of Mutations Causing Familial Hypercholesterolemia Clin. Chem., November 1, 2002; 48(11): 1913 - 1918. [Abstract] [Full Text] [PDF]

				E. J G Sijbrands, R. G J Westendorp, J. C Defesche, P. H E M de Meier, A. H M Smelt, J. J P Kastelein, and J. Kaprio Mortality over two centuries in large pedigree with familial hypercholesterolaemia: family tree mortality study Commentary: Role of other genes and environment should not be overlooked in monogenic disease BMJ, April 28, 2001; 322(7293): 1019 - 1023. [Abstract] [Full Text]

				J.T Real, F.J Chaves, I Martinez-Uso, A.B Garcia-Garcia, J.F Ascaso, and R Carmena Importance of HDL cholesterol levels and the total/ HDL cholesterol ratio as a risk factor for coronary heart disease in molecularly defined heterozygous familial hypercholesterolaemia Eur. Heart J., March 2, 2001; 22(6): 465 - 471. [Abstract] [PDF]

				K. E HEATH, R. A WHITTALL, G. J MILLER, and S. E HUMPHRIES I705 variant in the low density lipoprotein receptor gene has no effect on plasma cholesterol levels J. Med. Genet., September 1, 2000; 37(9): 713 - 715. [Full Text]

				L. Deiana, R. Garuti, G. M. Pes, C. Carru, A. Errigo, M. Rolleri, L. Pisciotta, P. Masturzo, A. Cantafora, S. Calandra, et al. Influence of {beta}0-Thalassemia on the Phenotypic Expression of Heterozygous Familial Hypercholesterolemia : A Study of Patients With Familial Hypercholesterolemia From Sardinia Arterioscler Thromb Vasc Biol, January 1, 2000; 20(1): 236 - 243. [Abstract] [Full Text] [PDF]

				M. C. Verhaar, M. L.H. Honing, T. van Dam, M. Zwart, H. A. Koomans, J. J.P. Kastelein, and T. J. Rabelink Nifedipine improves endothelial function in hypercholesterolemia, independently of an effect on blood pressure or plasma lipids Cardiovasc Res, June 1, 1999; 42(3): 752 - 760. [Abstract] [Full Text] [PDF]

				O. K. Rødningen, S. Tonstad, J. D. Medh, D. A. Chappell, L. Ose, and T. P. Leren Phenotypic consequences of a deletion of exons 2 and 3 of the LDL receptor gene J. Lipid Res., February 1, 1999; 40(2): 213 - 220. [Abstract] [Full Text]

				S. Bertolini, S. Cassanelli, R. Garuti, M. Ghisellini, M. L. Simone, M. Rolleri, P. Masturzo, and S. Calandra Analysis of LDL Receptor Gene Mutations in Italian Patients With Homozygous Familial Hypercholesterolemia Arterioscler Thromb Vasc Biol, February 1, 1999; 19(2): 408 - 418. [Abstract] [Full Text] [PDF]

				M. S. Nauck, H. Nissen, M. M. Hoffmann, J. Herwig, C. R. Pullinger, M. Averna, J. Geisel, H. Wieland, and W. Marz Detection of mutations in the apolipoprotein CII gene by denaturing gradient gel electrophoresis. Identification of the splice site variant apolipoprotein CII-Hamburg in a patient with severe hypertriglyceridemia Clin. Chem., July 1, 1998; 44(7): 1388 - 1396. [Abstract] [Full Text] [PDF]

				S. N. Pimstone, J. C. Defesche, S. M. Clee, H. D. Bakker, M. R. Hayden, and J. J.P. Kastelein Differences in the Phenotype Between Children With Familial Defective Apolipoprotein B-100 and Familial Hypercholesterolemia Arterioscler Thromb Vasc Biol, May 1, 1997; 17(5): 826 - 833. [Abstract] [Full Text]